From the Division of Molecular Immunology, Research Center for Infectious Diseases, Medical Institute of Bioregulation (Y.M., S.Y.), Department of Pediatrics, Graduate School of Medical Sciences (Y.M., S.K., H.N., T.H.), Kyushu University, Fukuoka, Japan; Laboratory of Immune Regulation, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan (K.A.); Department of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan (Y.H., H.K.); Laboratory for Cell Signaling, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan (T.S.); Laboratory for Cell Signaling, World Premier International Research Center, Immunology Frontier Research Center, Osaka University, Osaka, Japan (T.S.); Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga, Japan (H.H.); and Division of Molecular Immunology, Project for Host Response, Medical Mycology Research Center, Chiba University, Chiba, Japan (S.Y.).
Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1423-33. doi: 10.1161/ATVBAHA.114.304846. Epub 2015 Apr 2.
Nod1 is an intracellular pattern recognition receptor for bacterial peptidoglycan fragments. We previously reported that a synthetic Nod1 ligand, FK565, induced acute coronary arteritis in mice similar to that of Kawasaki disease. However, the molecular mechanisms underlying this characteristic inflammation have remained elusive.
We found that CD11c(+)MHC class II(+) cells accumulated in the heart of FK565-treated mice before arteritis development. Morphological features and gene expression signatures of the cardiac CD11c(+)MHC class II(+) cells suggested that this population is closely related to macrophages, and thus, we designated them cardiac CD11c(+) macrophages. Nod1 in nonhematopoietic cells, rather than hematopoietic cells, was required for the increase of cardiac CD11c(+) macrophages and arteritis development. Among nonhematopoietic cells, cardiac endothelial cells produced a large amount of chemokines in response to FK565. Endothelial cell-specific blockade of Nod1 signaling suppressed FK565-induced expression of these chemokines, accumulation of cardiac CD11c(+) macrophages, and subsequent coronary arteritis development. We also found that CCR2(+)Ly6C(hi) inflammatory monocytes in peripheral blood supplied precursors of cardiac CD11c(+) macrophages. CCR2-deficient mice or pertussis toxin-treated mice exhibited decreased numbers of cardiac CD11c(+) macrophages and reduced arteritis.
These results suggest that Ly6C(hi) monocytes are recruited to FK565-activated endothelial cells to generate cardiac CD11c(+) macrophages, which play a pivotal role in the pathogenesis of acute coronary arteritis.
Nod1 是一种识别细菌肽聚糖片段的细胞内模式识别受体。我们之前报道过,一种合成的 Nod1 配体 FK565 在小鼠中诱导类似于川崎病的急性冠状动脉炎。然而,这种特征性炎症的分子机制仍不清楚。
我们发现 FK565 治疗小鼠在动脉炎发生前心脏中积累了 CD11c(+)MHC Ⅱ(+)细胞。心脏 CD11c(+)MHC Ⅱ(+)细胞的形态特征和基因表达谱表明,该细胞群与巨噬细胞密切相关,因此我们将其命名为心脏 CD11c(+)巨噬细胞。非造血细胞而非造血细胞中的 Nod1 对于心脏 CD11c(+)巨噬细胞的增加和动脉炎的发展是必需的。在非造血细胞中,心脏内皮细胞对 FK565 反应产生大量趋化因子。内皮细胞特异性阻断 Nod1 信号通路抑制了 FK565 诱导的这些趋化因子的表达、心脏 CD11c(+)巨噬细胞的积累以及随后的冠状动脉炎的发展。我们还发现外周血中的 CCR2(+)Ly6C(hi)炎性单核细胞为心脏 CD11c(+)巨噬细胞提供了前体细胞。CCR2 缺陷小鼠或百日咳毒素处理小鼠心脏 CD11c(+)巨噬细胞数量减少,动脉炎减轻。
这些结果表明 Ly6C(hi)单核细胞被募集到 FK565 激活的内皮细胞中,产生心脏 CD11c(+)巨噬细胞,在急性冠状动脉炎的发病机制中发挥关键作用。